ScholarIQanswers from OpenAlex & ORCID
Alan Prem Kumar
ResearcherPublications, citations & collaboration network
Alan Prem Kumar is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Alan Prem Kumar have?
ScholarIQindexed works
Alan Prem Kumar has 374 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Alan Prem Kumar have?
ScholarIQcitation count
Alan Prem Kumar has 27,240 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Alan Prem Kumar?
ScholarIQh-index
Alan Prem Kumar has an h-index of 94 in OpenAlex.
What is the i10-index of Alan Prem Kumar?
ScholarIQi10-index
Alan Prem Kumar has an i10-index of 235 in OpenAlex.
What is the ORCID of Alan Prem Kumar?
ScholarIQorcid
The ORCID for Alan Prem Kumar is on the source record.
What is the OpenAlex record for Alan Prem Kumar?
ScholarIQopenalex
The OpenAlex for Alan Prem Kumar is on the source record.
What are the most-cited papers on Alan Prem Kumar?
ScholarIQmost cited works
Emerging role of exosomes in cancer progression and tumor microenvironment remodeling
Mahshid Deldar Abad Paskeh, Maliheh Entezari, Sepideh Mirzaei, Amirhossein Zabolian, Hossein Saleki, Mohamad Javad Naghdi, Sina Sabet, Mohammad Amin Khoshbakht, Mehrdad Hashemi, Kiavash Hushmandi, Gautam Sethi, Ali Zarrabi, Alan Prem Kumar, Shing Cheng Tan, Marios Papadakis, Αθανάσιος Αλεξίου, Md Asiful Islam, Ebrahim Mostafavi, Milad Ashrafizadeh
Dual role of autophagy in hallmarks of cancer
Shikha Satendra Singh, Somya Vats, Amelia Yi-Qian Chia, Tuan Zea Tan, Shuo Deng, Mei Shan Ong, Frank Arfuso, Celestial T. Yap, Boon Cher Goh, Gautam Sethi, Ruby Yun‐Ju Huang, Han‐Ming Shen, Ravi Manjithaya, Alan Prem Kumar
Stimuli-responsive liposomal nanoformulations in cancer therapy: Pre-clinical & clinical approaches
Milad Ashrafizadeh, Masoud Delfi, Ali Zarrabi, Ashkan Bigham, Esmaeel Sharifi, Navid Rabiee, Ana Cláudia Paiva‐Santos, Alan Prem Kumar, Shing Cheng Tan, Kiavash Hushmandi, Jun Ren, Ehsan Nazarzadeh Zare, Pooyan Makvandi
RETRACTED: New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities
Milad Ashrafizadeh, Sepideh Mirzaei, Farid Hashemi, Ali Zarrabi, Amirhossein Zabolian, Hossein Saleki, Seyed Omid Sharifzadeh, Leyla Soleymani, Salman Daneshi, Kiavash Hushmandi, Haroon Khan, Alan Prem Kumar, Amir Reza Aref, Saeed Samarghandian